Pathologic Complete Response of Pancreatic Cancer following Neoadjuvant FOLFIRINOX Treatment in Hepatic Metastasized Pancreatic Cancer.

Luu, Andreas Minh; Hoehn, Philipp; Vogel, Sina Rabea; Reinacher-Schick, Anke; Munding, Johanna; Uhl, Waldemar; Braumann, Chris

Luu, Andreas Minh; Hoehn, Philipp; Vogel, Sina Rabea; Reinacher-Schick, Anke; Munding, Johanna; Uhl, Waldemar; Braumann, Chris.

Afiliação

Luu AM; Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Hoehn P; Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Vogel SR; Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Reinacher-Schick A; Department of Oncology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Munding J; Institute of Pathology, University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Uhl W; Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
Braumann C; Department of General and Visceral Surgery, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.

Visc Med ; 35(6): 387-391, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31934588

Palavras-chave

FOLFIRINOX; Hepatic metastases; Pancreatic cancer; Pathologic complete response; ypT0

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Visc Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google